COVID-19 Update: UH has visitor restrictions in place to protect patients and staff against coronavirus. Permitted visitors will be screened for flu-like symptoms. Click here for additional information on non-essential appointments, testing locations, COVID-19 information and how you can help during this crisis.

UH Seidman Cancer Center

Gastrointestinal Oncology Program

Download Gastroenterology Oncology Program

HOSPITAL
University Hospitals Seidman Cancer Center

KEY CONTACTS
Amitabh Chak, MD, Gastroenterology 216-844-3217, Amitabh.Chak@UHhospitals.org
Jennifer Dorth, MD, Discipline Lead, Radiation Oncology 216-286-3903, Jennifer.Dorth@UHhospitals.org
Jennifer Eads, MD, Upper GI Disease Team Leader, Medical Oncology 216-844-6003, Jennifer.Eads@UHhospitals.org
Jeffrey Hardacre, MD, Discipline Lead, Surgical Oncology 216-844-7047, Jeffrey.Hardacre@UHhospitals.org
Richard Lee, MD, Integrative Oncology, Palliative Care, Hepatocellular Cancer 216-844-5884, Richard.Lee@UHhospitals.org
Philip Linden, MD, Esophageal Surgery 216-844-0065, Philip.Linden@UHhospitals.org

APPOINTMENT LINE
Please call Jeanie Wyckhouse, New Patient Access Coordinator, at 216-844-5020 or email Jeanie.Wyckhouse@UHhospitals.org.
For hospital transfers, please call 216-844-1111.

Conditions Treated

  • Esophagogastric cancers, including Barrett’s esophagus
  • Biliary cancers
  • Pancreatic cancers: pancreatic adenocarcinoma, pancreatic cystic neoplasms, pancreatic neuroendocrine tumors and rare pancreatic tumors
  • Small intestinal cancers
  • Colorectal cancers
  • Anal cancers
  • Gastrointestinal stromal tumors
  • Neuroendocrine cancers

Procedures and Therapies

  • Endoscopic ultrasound, endoscopic mucosal resection and endoscopic submucosal dissection for the staging and treatment of early esophageal cancers
  • Noninvasive treatments (stenting, robotic and laparoscopic procedures, transanal resections)
  • Liver-directed therapies, including resection of metastases, surgical ablation, transarterial chemoembolization, radioembolization and percutaneous microwave ablation
  • Colo-anal reconstruction/sphincter-sparing surgery
  • Enhanced recovery programs following colorectal surgery
  • Radiation therapy, including proton beam therapy, IMRT and MR planning, and intraoperative radiation
  • Chemotherapy and immunotherapy, including clinical trials

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Center
  • Multidisciplinary consultation and disease-specific tumor boards
  • First in Northeast Ohio to perform minimally invasive esophagectomy
  • Lowest esophagectomy mortality rate in the nation
  • One of three NCI Barrett’s Esophagus Translational Research Network centers, via Case Western Reserve University
  • Innovative clinical trials of new treatments
  • One of six National Cancer Institute Specialized Programs of Research Excellence (SPORE) centers for gastrointestinal cancers in the U.S., via Case Western Reserve University
  • National leadership in clinical pathway development
  • Noninvasive diagnostic technology using new imaging methodologies
  • First Proton Therapy Center in Ohio
  • Genetic analysis of tumors to guide personalized therapy
  • Genetic risk assessment to guide preventive strategies in cancer-prone families
  • Supportive and Integrative Oncology program
  • Specialized Adolescent and Young Adult (AYA) cancer program
Back to Top